Dysfunctional regulation of inflammation may contribute to the progression of neurodegenerative diseases. The results of this study revealed that DJ-1, a Parkinson's disease (PD) gene, regulated expression of prostaglandin D 2 synthase (PTGDS) and production of prostaglandin D 2 (PGD 2 ), by which DJ-1 enhanced anti-inflammatory function of astrocytes. In injured DJ-1 knockout (KO) brain, expression of tumor necrosis factor-alpha (TNF- was more increased, but that of antiinflammatory heme oxygenase-1 (HO-1) was less increased compared with that in injured wild-type (WT) brain. Similarly, astrocyte-conditioned media (ACM) prepared from DJ-1-KO astrocytes less induced HO-1 expression and less inhibited expression of inflammatory mediators in microglia. With respect to the underlying mechanism, we found that PTGDS that induced expression of HO-1 was lower in DJ-1 KO astrocytes and brains compared with their WT counterparts. In addition, PTGDS levels increased in the injured brain of WT mice, but barely in that of KO mice. We also found that DJ-1 regulated PTGDS expression through Sox9. Thus, Sox9 siRNAs reduced PTGDS expression in WT astrocytes, and Sox9 overexpression rescued PTGDS expression in DJ-1 KO astrocytes. In agreement with these results, ACM from Sox9 siRNA-treated astrocytes and that from Sox9-overexpression astrocytes exerted opposite effects on HO-1 expression and anti-inflammation. These findings suggest that DJ-1 positively regulates anti-inflammatory functions of astrocytes, and that DJ-1 dysfunction contributes to the excessive inflammatory response in PD development.
Introduction
Parkinson's disease (PD) is a neurodegenerative disease characterized by the loss of dopaminergic neurons in the substantia nigra (Hirsch et al., 1988) . DJ-1, PARK7, is an early onset autosomal-recessive PD-related gene (Bonifati et al., 2003) , which is reported to have diverse functions including regulation of apoptosis, oxidative stress and astrogliosis (Choi et al., 2018; Junn et al., 2005; Mullett and Hinkle, 2009) . Some studies have also reported that DJ-1 is a negative regulator of inflammation (Kim et al., 2013b; Kim et al., 2014; Waak et al., 2009 ).
Brain inflammation that occurs in injured brain protects tissues and repair of injured tissues (Jeong et al., 2013a; Tsarouchas et al., 2018) . However, uncontrolled brain inflammation can increase tissue damage and be a risk factor of neurodegenerative diseases such as PD, AD and multiple sclerosis (Breitner, 1996; Chen et al., 2003; Klegeris and McGeer, 2005; Raivich and Banati, 2004; Sheng et al., 1998) . Thus, there are two main mechanisms that control brain inflammation through the expression of pro-inflammatory mediators and anti-inflammatory mediators (Min et al., 2006) . Astrocytes, the most abundant cells in the brain, produce anti-inflammatory factors of which induce the activation of transcription factor nuclear factor-like 2 (Nrf2) and subsequently induces the expression of antioxidant enzymes such as heme oxygenase-1 (HO-1) in microglia (Min et al., 2006) . Thus, alteration or loss of astrocyte anti-inflammatory functions can enhance brain inflammation and contributes to the progression of neurodegenerative diseases.
It has been reported that prostaglandin D 2 (PGD 2 ), which is the most abundant prostaglandin in the CNS (Narumiya et al., 1982) , also has anti-inflammatory effects (Kuesap et al., 2008; Satarug et al., 2008) . It binds to DP2 receptors and activates the phosphatidylinositol 3-kinase (PI3K)/AKT signal pathway to increase HO-1 expression (Kuesap et al., 2008; Satarug et al., 2008) . PGD 2 is produced by two types of PGD synthases (PGDS): hematopoietic-type PGDS (H-PGDS) and prostaglandin D 2 synthase (PTGDS, lipocalin type PGDS, L-PGDS). In the brain, PTGDS is the major enzyme that produces PGD 2 (Urade and Eguchi, 2002; Urade and Hayaishi, 2000) , and also protects neurons from oxidative stress and ischemic injury (Fukuhara et al., 2012; Saleem et al., 2009; Taniike et al., 2002) . Notably, it has been reported that PGD 2 and PTGDS are linked with neurodegenerative disease and brain injury; PGD 2 levels are increased in AD patients compared with
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In this study, it was found that DJ-1 deficiency weakens the anti-inflammatory function of astrocytes through reduced PTGDS expression and subsequent PGD 2 production. In addition, the transcription factor Sox9 which is stabilized by DJ-1, regulates PTGDS expression.
A C C E P T E D M A N U S C R I P T

Materials and methods
Study approval
All experiments were performed in an accordance with approved animal protocols and guidelines established by the Ajou University School of Medicine Ethics Review Committee for animal experiments, and all animal work was approved by the Ethical Committee for Animal
Research of Ajou University (2014-0029; AMC119).
DJ-1 deficient mice
The DJ-1 KO mice (C57BL/6 background, male, 8-10 weeks old) used in this study were a generous gift from Prof. UJ Kang and Prof. X Zhuang (Chicago University, Chicago, IL, USA). DJ-1 KO mice were previously generated by deleting a 9.3-kb region of genomic DNA containing the first five exons and part of the promoter region of the DJ-1 gene (Chen et al., 2005) .
Cell culture
Primary astrocytes were cultured from the brain of c57/BL6 WT and DJ-1 KO mouse. In briefly, meninges were removed, and brain was mechanically dissociated with gentle pipetting in the media. Dissociated cells in DMEM (Hyclone, Logan, UT, USA) containing 10% FBS (Hyclone) were seeded on 75 cm 2 T-flasks (0.5 hemisphere/flask), and were incubated in 37°C, 5% CO 2 incubator for 2-3 weeks. Astrocytes were removed with 0.1% trypsin and seeded on culture dishes.
BV2 murine microglia was cultured in DMEM containing 5% FBS as previously described (Min et al., 2006) . For activation, cells were treated with 20 ng/ml recombinant murine IFN- (PeproTech, Rocky Hill, NJ, USA). PGD2 receptor antagonists (BWA868C for DP1; CAY10471 for A C C E P T E D M A N U S C R I P T cocktails (GenDEPOT, Baker, TX, USA). Proteins were separated by sodium dodecyl sulfatepolyacrylamide gel electrophoresis (SDS-PAGE) and transferred to nitrocellulose membranes.
Membranes were incubated with primary antibodies (Supplemental Table 2 ) overnight at 4°C.
Membranes were washed with Tris-buffered saline containing 0.1% Tween 20 (TBST), incubated with secondary antibodies, and visualized with an enhanced chemiluminescence system (Daeil Lab Inc., Seoul, Korea). Band intensities were measured using Image J.
Quantitative real-time polymerase chain reaction (qPCR)
Total RNA was isolated from cells and brains using easy-BLUE reagent (iNtRON Biotechnology, Seoul, Korea). cDNA was synthesized using a cDNA synthesis kit (iNtRON) following the manufacturer's guidance. The relevant mRNA levels were measured using a KAP SYBR FAST qPCR kit (Kapa Biosystems, Boston, MA, USA) and a RotoGene thermocycler (Corbett Research, Sydney, Australia). The primer pairs used in this study were summarized (Supplemental Table 3 ). The cycle threshold (Ct) for the target gene transcript was normalized to the average Ct for -actin, and the relative quantitation of normalized transcript abundance was determined using the comparative Ct method (Ct), as described by the manufacturer.
Stereotaxic injection
Male mice (8-10 weeks old) were anesthetized by intraperitoneal injection of tribromoethanol (250 mg/kg; Sigma, St. Louis, MO, USA) and positioned in a stereotaxic apparatus (David Kopf Instruments, Tujunga, CA, USA). Brain injury was produced by unilateral administration of ATP (400 nmole; Sigma) into the striatum (AP, +0.2 mm; ML, -2.5 mm; DV, -3 mm from bregma), according to stereotaxic coordinates in The Atlas of the Mouse Brain (Paxinos and Franklin, second edition), as previously described (Jeong et al., 2010) . All animals were injected using a Hamilton syringe attached to a syringe pump and equipped with a 30-gauge blunt-ended needle to minimize mechanical damage (KD Scientific, New Hope, PA, USA). ATP was dissolved in sterile phosphate -A C C E P T E D M A N U S C R I P T buffered saline (PBS), and 0.8 l of ATP solution was infused at a rate of 0.2 l/min. After injection, the needle was held in place for an additional 4 min before removal. The contralateral side was used as a control.
Tissue preparation
For immunostaining, mice were anesthetized and transcardially perfused first with saline solution containing 0.5% sodium nitrate and heparin (10 U/ml), and then with 4% paraformaldehyde in 0.1 M phosphate buffer (PB; pH 7.2). Brains were stored at 4°C in 4% paraformaldehyde for 2 d, and then in a 30% sucrose solution until they sank. Six separate series of 40-m coronal brain sections were obtained using a Model CM3050S cryostat (Leica, Wetzlar, Germany) and stored in an antifreeze stock solution (PB containing 30% glycerol and, 30% ethylene glycol, pH 7.2) at 4°C before use.
For mRNA and protein preparation, brains were removed and sliced with an Alto mouse brain slicer matrix (SA-2175; Roboz Surgical Instruments, Gaithersburg, MD, USA) and a razor blade.
Slices (1 mm thickness) surrounding the needle injection spot were collected and stored at -70°C until use.
Immunohistochemistry
Sections or cultures were washed with PBST, treated with 1% BSA, and incubated with combinations of primary antibodies (Supplemental Table 2 ). Immunoreactive proteins were visualized using Alexa Fluor 488-or Alexa Fluor 555-conjugated secondary antibodies (1:600 dilution;
Invitrogen, Carlsbad, CA, USA). Sections were counterstained with 4', 6-diamidino-2-phenylindol (DAPI; Vector Laboratories) to detect nuclei. Images were captured using a confocal microscope (Carl Zeiss, Oberkochen, Germany). Protein intensities were analyzed using Image J (NIH, Bethesda, MD, USA).
Differentially expressed genes (DEGs) analysis
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For analysis about expression of prostaglandin synthase family between WT and DJ-1 KO rat brain, NGS dataset was downloaded from GEO (GSE71968) (Hauser et al., 2017) . For analysis about expression of prostaglandin synthase in astrocytes on each other region, NGS dataset was downloaded from publishing paper (Clarke et al., 2018) . Gene expression was analyzed by R studio.
Statistical analysis
The statistical significance of differences between two groups was determined using unpaired two-tailed Student's t tests. For comparisons of multiple means, statistical significance was determined by One-way analysis of variance (ANOVA) followed by a Newman-Keuls post hoc test using Graph Pad Prism 5 (GraphPad Software, La Jolla, CA, USA).
Data availability statement
The data that support the findings of this study are available from the corresponding author upon reasonable request.
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Results
DJ-1 deficiency attenuates anti-inflammatory function of astrocytes
Inflammation could be enhanced by a decreased in the expression of anti-inflammatory mediators as well as an increase in the expression of pro-inflammatory mediators. In our previous studies, soluble factors from astrocytes prevented excessive inflammation of microglia (Kim et al., 2010; Min et al., 2006; Pyo et al., 2003) . Thus, this study examined whether a DJ-1 deficiency altered the anti-inflammatory function of astrocytes. For this, we examined expression levels of tumor necrosis factor-alpha (TNF- and heme oxygenase-1 (HO-1) in injured WT and DJ-1 KO brains as markers of pro-and anti-inflammation, respectively (Kim et al., 2010; Min et al., 2006; Pyo et al., 2003) . We used ATP, which is a damage-associated molecular patterns (DAMPs), to induce brain damage as reported in previous studies (Choi et al., 2018; Jeong et al., 2010; Jeong et al., 2013b) .
Interestingly, the expression of TNF- and HO-1 showed opposing patterns in WT and KO brains at 6 h after ATP injection. TNF- expression had increased; however, HO-1 expression had decreased in DJ-1 KO brains compared to WT brains (Fig. 1A) . Next, we compared the anti-inflammatory effect of astrocyte conditioned media (ACM) prepared from WT (WT-ACM) and DJ-1 KO astrocytes (KO-ACM) by measuring TNF-and HO-1 expression in BV2 microglia, since HO-1 is a mediator of antiinflammatory function of astrocytes (Kim et al., 2010; Min et al., 2006; Pyo et al., 2003) . Interestingly, KO-ACM had a weak effect on reducing TNF- expression induced by interferon-gamma (IFN- compared with WT-ACM. Whilst WT-ACM increased HO-1 mRNA and protein expression approximately 2 fold and 1.5 fold within 3, 6 h, but KO-ACM barely increased its expression (Fig.1B,   C ). We also found that HO-1 protein expression was rescued by ACM from DJ-1 KO astrocytes transfected with hDJ-1 (hDJ-1 KO-ACM) but not by those transfected with a control vector (Mock KO-ACM) (Fig. 1D ). Similar effect was obtained on iNOS expression: compared with WT-ACM, KO-ACM had a weak effect on reducing iNOS expression in IFN--treated microglia (Fig. 1E) , and the anti-inflammatory function of KO-ACM was rescued by hDJ-1 KO-ACM (Fig. 1F) . These results suggest that attenuation of astrocyte anti-inflammatory function may enhance brain inflammation in DJ-1 deficient mouse brain.
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To identify the anti-inflammatory factors of astrocytes that are regulated by DJ-1, we analyzed the RNA sequencing datasets of WT and DJ-1 KO rat brains provided by GEO (GSE71968) (Hauser et al., 2017) and found the possibility that the prostaglandin synthases were a candidate since products of these enzymes induce HO-1 expression and regulate inflammatory responses (Ricciotti and FitzGerald, 2011) . Using qPCR analysis, we found reduced mRNA expression of PTGDS in DJ-1 KO brains (Fig 2B) . However, levels of other prostaglandin synthases including prostaglandin E synthase (PTGES) and prostaglandin I 2 synthase (PTGIS) showed little difference in WT and KO brains, and hematopoietic prostaglandin D synthase (HPGDS) levels were rather higher in DJ-1 KO brain (Fig. 2B) . In a western blot, PTGDS levels were also lower in DJ-1 KO brains (Fig. 2C ). In addition, interestingly, we found that PTGDS was a major prominent prostaglandin synthase of astrocytes in further analysis of RNA sequencing datasets reported by others (Clarke et al., 2018) (Fig.   2D ). Based on this information, we examined whether PTGDS could be an anti-inflammatory factor of astrocytes and whether DJ-1 regulated the level of PTGDS. Both western blot and qPCR analyses showed that PTGDS levels in DJ-1 KO astrocytes were less than 50% of those in WT astrocytes ( Fig.   2E upper panel, Fig. 2F ). However, levels of other prostaglandin synthases showed slight change in WT and DJ-1 KO astrocytes (Supplemental Fig. 1A, B) . In addition, transfected hDJ-1 increased PTGDS mRNA and protein levels in DJ-1 KO astrocytes (Fig. 2E lower panel, G) .
Next, we analyzed PTGDS expression in intact and injured brains. Brain sections were obtained at 6 h after ATP injection, and stained with antibodies specific for PTGDS and S100, a marker of astrocytes. PTGDS expression was found in S100-positive astrocytes in intact brain, and its level increased in response to injury (Fig. 3A-C) . However, PTGDS levels in DJ-1 KO brains were lower than in WT brains in both intact (Contra) and injury states (Ipsi) (Fig. 3A-C) . As for staining, PTGDS mRNA levels in DJ-1 KO brains were lower in intact states than in WT brains (Fig. 3D ). In addition, PTGDS mRNA levels had increased in ATP-injected WT brains but not KO brains (Fig. 3D) .
However, mRNA levels of PTGES, PTGIS, and HPGDS were similar in the WT and DJ-1 KO brains
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We further confirmed PTGDS as an active anti-inflammatory factor of astrocytes with knock down of PTGDS in WT astrocytes (Fig. 4A, Supplemental Fig. 3A, B) and/or overexpression of PTGDS in DJ-1 KO astrocytes (Fig. 4D, Supplemental Fig. 3C ). siRNAs specific for PTGDS effectively decreased the expression of PTGDS in astrocytes (Supplemental Fig. 3A, B) . ACMs (siPTGDS-1/2 ACM) prepared from PTGDS siRNAs treated astrocytes less induced HO-1 expression (Fig. 4B) , and less inhibited IFN--induced iNOS expression in microglia than the ACM from nontargeted (NT) siRNA-treated astrocytes (Fig. 4C ). In addition, ACM (PTGDS ACM) from PTGDSoverexpressing DJ-1 KO astrocytes significantly induced HO-1 expression and inhibited iNOS expression than empty-vector expressing (Mock) astrocytes (Fig. 4E, F) .
It has been reported that PGD 2 , a product of PTGDS (Eguchi et al., 1999; Eichele et al., 2008) , induces HO-1 expression in several types of cells (Kuesap et al., 2008; Satarug et al., 2008) .
Therefore, we measured the levels of PGD 2 in WT-and DJ-1 KO ACM using ELISA: PGD 2 levels in DJ-1 KO ACM were about 40-50% of that in WT ACM (Fig. 5A ). In addition, ACM-induced HO-1 expression in microglia was inhibited by DP2 PGD 2 receptor antagonists, CAY10471, but not by a DP1 antagonist, BW A868C (Fig. 5B ). Since PGD 2 induces HO-1 expression through AKT activation (Jeong et al., 2018) , we further examined the levels of AKT activation in WT ACM-and KO ACMtreated microglia. As expected, DJ-1 KO ACM less increased phosphor-AKT (pAKT) levels than WT ACM (Fig. 5C ). In addition, WT ACM-induced HO-1 induction was reduced by wortmannin and LY294002, inhibitors of PI3K, an upstream kinase of AKT (Fig. 5D ). Taken together, these results suggest that DJ-1 deficiency reduced PGD 2 production and PTGDS from astrocytes, resulting in reduced microglial HO-1 expression and subsequently attenuated anti-inflammatory function.
Sox9 regulates PTGDS expression in astrocytes
Next, we investigated how DJ-1 regulates PTGDS expression in astrocytes. It has been reported that Sox9 regulates mRNA levels of PTGDS (Wilhelm et al., 2007) . Furthermore, we recently reported that DJ-1 is important for stabilization of Sox9 protein through inhibition of Sox9
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ubiquitination (Choi et al., 2018) . Based on the information, we analyzed whether the defect of Sox9 in DJ-1 KO astrocytes was related to the reduction in PTGDS expression using siRNA specific for Sox9. Interestingly, Sox9 siRNA (siSox9 1/2) reduced mRNA levels of PTGDS in WT astrocytes (Fig.   6B ). Accordingly, ACM (siSox9-1/2 ACM) obtained from siSox9 treated astrocytes less reduced iNOS expression in IFN--treated microglia compared with ACM from siNT-treated astrocytes (Fig.   6C ), and less induced HO-1 expression (Fig. 6D ). In addition, altered PTGDS expression was rescued by Sox9 overexpression in DJ-1 KO astrocytes (Fig. 6F) . Accordingly, ACM from Sox9-overexpressing astrocytes significantly reduced IFN--induced iNOS expression, and more strongly increased HO-1 expression in microglia (Fig. 6G, H) . Taken together, these results indicate that DJ-1 deficiency reduced Sox9 levels and subsequently PTGDS expression in astrocytes, by which DJ-1 deficiency reduced anti-inflammatory function of astrocytes.
Discussion
The results of this study show that a DJ-1 deficiency in astrocytes reduced PTGDS expression and subsequent PGD 2 secretion, by which astrocytic anti-inflammatory functions were attenuated. In addition, PTGDS expression was closely related with Sox9 levels in astrocytes. Thus, reduced Sox9 levels in DJ-1 KO astrocytes resulted in reduced PTGDS expression.
Inflammation accompanied with injury may aggravate the injury (Breitner, 1996; Chen et al., 2003; Klegeris and McGeer, 2005; Raivich and Banati, 2004; Sheng et al., 1998) . Therefore, brain inflammation should be tightly regulated since neurons are rarely regenerated once damaged. There are diverse mechanisms that regulate brain inflammation: turning on expression of negative regulators of inflammation and turning off signaling pathways for activation of inflammation in microglia and astrocytes, etc., (Yang et al., 2007) . It has been reported that DJ-1 regulates inflammation in several ways: DJ-1 negatively regulates STAT1 activation through enhancing interaction between STAT1 and its phosphatase, SHP1 (Kim et al., 2013b) , and/or enhancing expression of SOCS1, a negative regulator of STAT1, through mir-155 (Kim et al., 2014) . Since astrocytes induce anti-inflammatory molecules in microglia (Min et al., 2006) , and DJ-1 is expressed in astrocytes (Waak et al., 2009 ), we hypothesized DJ-1 may regulate inflammation through anti-inflammatory roles of astrocytes. As expected, DJ-1 KO ACM induced HO-1 expression in microglia less strongly than WT ACM (Fig. 1B,   C ), subsequently exerted less inhibitory effect on IFN--induced iNOS and TNF- expression (Fig.1B,   E ). In addition, defective anti-inflammatory functions of KO ACM were rescued by DJ-1 overexpression (Fig. 1D, F) . Therefore, it is evident that DJ-1 regulates brain inflammation via two mechanisms: direct regulation of pro-inflammatory mediator expression in microglia, and indirect regulation of anti-inflammatory functions of astrocytes.
With regard to the anti-inflammatory factors produced by astrocytes, several molecules have been suggested, transforming growth factor (TGF)- (da Cunha and Vitkovic, 1992; Vincent et al., 1997) , dehydroepiandrosterone (DHEA), a neurosteroid (Zwain and Yen, 1999) , and prostaglandins including PGE 2 (Molina-Holgado et al., 2000; Taniura et al., 2002) . These molecules exert antiinflammatory effects regulating signaling pathways such as JAK-STAT, MAP kinase and NF-kB. (Altman et al., 2008; Qian et al., 2008) . Our previous study reported that soluble factors produced by ACCEPTED MANUSCRIPT
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astrocytes in intact and injury states was heat-labile and smaller than 3kDa, and induced HO-1 in microglia (Kim et al., 2010; Min et al., 2006) . The results of this study showed that PGD 2 could be an active molecule in ACM because it is released from astrocytes, and induced HO-1 expression in microglia ( Fig. 5A-D) . In addition, levels of PGD 2 were reduced in DJ-1 KO ACM (Fig. 5A ) and were due to reduced levels of PTGDS (Fig. 2) . Although PGD 2 is also produced by another prostaglandin D 2 synthase, HPGDS, HPGDS levels were rather slightly increased in (Fig.2, Supplemental Fig.1 ) and its induction rate was not changed in intact or injured DJ-1 KO brain compared with WT (Supplemental Fig.2 ). In addition, PTGDS levels increased in response to injury in WT brain but barely in the DJ-1 KO brain (Fig. 3) , which may reduce anti-inflammatory function of DJ-1 KO astrocytes and subsequently increase inflammation in injured DJ-1 KO brain.
Next arising question was how DJ-1 regulates PTGDS expression in astrocytes. Our previous study revealed that DJ-1 stabilized Sox9 at protein level through inhibition of Sox9 ubiquitination (Choi et al. 2018 ), but not directly binding effect (Supplemental Fig. 4) . Furthermore, it has been reported that in sertoli cells PTGDS expression is regulated by Sox9 (Wilhelm et al., 2007) . In astrocytes, Sox9 regulates PTGDS expression: PTGDS levels were reduced by Sox9 siRNA in WT astrocytes (Fig. 6B) , and enhanced by Sox9 overexpression in DJ-1 KO astrocytes (Fig. 6F) .
Accordingly, Sox9 siRNA and overexpression showed opposite effects on HO-1 expression and antiinflammatory functions of ACM (Fig. 6C , D vs. Fig. 6G, H) . These results suggest that DJ-1 deficiency decrease PTGDS expression and PGD 2 production due to Sox9 protein destabilization. We and others have reported diverse functions Sox9 in the brain including regulation of gliogenesis during brain development (Cheng et al., 2009; Kang et al., 2012) , regulation of astrogliosis in injured brain (Kordes and Hagel, 2006; McKillop et al., 2013) , and expression of growth factors including BDNF and GDNF (Choi et al., 2018) . The present findings revealed another function of Sox9, regulation of brain inflammation through the expression of PTGDS which catalyzes PGD 2 production and subsequently increases HO-1 expression. Taken together, Sox9 could be a target to regulate A C C E P T E D M A N U S C R I P T two tailed t-test (A) and one way ANOVA followed by a Newman-Keuls post hoc test (B-F), which is contained statistical summary (n.s, nonsignificant; *P < 0.05, **P < 0.005; ***P < 0.001). Values are means ± SEMs of three samples. p values were calculated from unpaired two tailed t-test (A-C, E-G) and one way ANOVA followed by a Newman-Keuls post hoc test (D), which is contained statistical summary (***P < 0.001). which is contained statistical summary (**P < 0.005; ***P < 0.001).
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